• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

图像细胞术DNA倍体与子宫内膜癌的组织学亚型相关。

Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas.

作者信息

Pradhan Manohar, Abeler Vera M, Danielsen Håvard E, Tropé Claes G, Risberg Björn Ake

机构信息

Pathology Clinic, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway.

出版信息

Mod Pathol. 2006 Sep;19(9):1227-35. doi: 10.1038/modpathol.3800641. Epub 2006 May 26.

DOI:10.1038/modpathol.3800641
PMID:16729014
Abstract

Image cytometric DNA ploidy analysis of endometrial carcinomas was performed to determine whether ploidy status and ploidy-related parameters like DNA index, percentage of cells exceeding 5c and 9c, correlate with histologic subtype. This is a prospective study of 391 patients with stage I endometrial carcinoma which included 331 (85%) endometrioid adenocarcinoma, 22 (6%) serous adenocarcinoma, 7 (2%) clear cell adenocarcinoma, 2 (0.5%) small cell carcinoma, 1 (0.3%) undifferentiated carcinoma, and 28 (7%) unclassifiable adenocarcinoma. Twenty-five percent of endometrioid adenocarcinomas were non-diploid. In contrast, all clear cell adenocarcinomas and 21/22 (95%) of serous adenocarcinomas were non-diploid. Hyperdiploidy (25 cases) was found only in endometrioid adenocarcinomas. Mean DNA index of the stemline in serous adenocarcinoma (1.72) and clear cell adenocarcinoma (1.81) was higher than in endometrioid adenocarcinoma (1.1). The difference in ploidy-related parameters between endometrioid adenocarcinoma and serous adenocarcinoma was highly significant (P<0.001). In addition, Grade 3 endometrioid adenocarcinoma showed significant difference in all ploidy-related parameters compared with grade 1 and grade 2 tumors (P<0.001). Our results show that DNA ploidy-related parameters may be valuable in subtyping histologically difficult cases of endometrial carcinomas.

摘要

对子宫内膜癌进行图像细胞术DNA倍体分析,以确定倍体状态以及诸如DNA指数、超过5c和9c的细胞百分比等倍体相关参数是否与组织学亚型相关。这是一项对391例I期子宫内膜癌患者的前瞻性研究,其中包括331例(85%)子宫内膜样腺癌、22例(6%)浆液性腺癌、7例(2%)透明细胞腺癌、2例(0.5%)小细胞癌、1例(0.3%)未分化癌以及28例(7%)无法分类的腺癌。25%的子宫内膜样腺癌为非二倍体。相比之下,所有透明细胞腺癌以及22例中的21例(95%)浆液性腺癌均为非二倍体。超二倍体(25例)仅在子宫内膜样腺癌中发现。浆液性腺癌(1.72)和透明细胞腺癌(1.81)的干系平均DNA指数高于子宫内膜样腺癌(1.1)。子宫内膜样腺癌和浆液性腺癌之间倍体相关参数的差异具有高度显著性(P<0.001)。此外,3级子宫内膜样腺癌与1级和2级肿瘤相比,在所有倍体相关参数上均显示出显著差异(P<0.001)。我们的结果表明,DNA倍体相关参数可能有助于对组织学诊断困难的子宫内膜癌病例进行亚型分类。

相似文献

1
Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas.图像细胞术DNA倍体与子宫内膜癌的组织学亚型相关。
Mod Pathol. 2006 Sep;19(9):1227-35. doi: 10.1038/modpathol.3800641. Epub 2006 May 26.
2
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.DNA 倍性可能是 I 期和 II 期子宫内膜浆液性腺癌的预后标志物。
Virchows Arch. 2012 Sep;461(3):291-8. doi: 10.1007/s00428-012-1275-2. Epub 2012 Jul 24.
3
Endometrial carcinomas--flow cytometric DNA content and S-phase values.子宫内膜癌——流式细胞术DNA含量及S期值
Pathol Res Pract. 1997;193(4):283-90. doi: 10.1016/S0344-0338(97)80005-2.
4
PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.PIK3CA 错义突变与 3 级子宫内膜样癌的不良预后相关,但与浆液性子宫内膜癌无关。
Gynecol Oncol. 2014 Jan;132(1):188-93. doi: 10.1016/j.ygyno.2013.11.015. Epub 2013 Nov 19.
5
Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.子宫内膜癌的免疫组织化学特征:子宫内膜样癌、浆液性癌和透明细胞腺癌与基因分析
J Obstet Gynaecol Res. 2014 Dec;40(12):2167-76. doi: 10.1111/jog.12564. Epub 2014 Nov 3.
6
Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications.浆液性交界性肿瘤与浆液性腺癌之间的基因组总体改变存在差异——对307例病例的图像细胞术DNA倍体分析及其组织发生学意义
Virchows Arch. 2009 Jun;454(6):677-83. doi: 10.1007/s00428-009-0778-y. Epub 2009 May 8.
7
Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy.子宫内膜腺癌细胞核DNA含量的流式细胞术分析。非典型有丝分裂与DNA非整倍体相关。
Am J Clin Pathol. 1994 Sep;102(3):341-8. doi: 10.1093/ajcp/102.3.341.
8
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.与高危型子宫内膜上皮癌相比,子宫内膜癌肉瘤具有不同的预后和扩散模式。
Gynecol Oncol. 2005 Aug;98(2):274-80. doi: 10.1016/j.ygyno.2005.04.027.
9
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.子宫内膜腺癌的免疫表型多样性:对鉴别诊断的意义。
Mod Pathol. 2006 Aug;19(8):1091-100. doi: 10.1038/modpathol.3800620. Epub 2006 Apr 28.
10
Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.子宫内膜样癌、透明细胞癌及浆液性癌患者的细胞凋亡以及Bcl-2和Bax的表达
Gynecol Oncol. 2001 May;81(2):178-83. doi: 10.1006/gyno.2001.6138.

引用本文的文献

1
DNA ploidy combined with tumor stroma as a biomarker for predicting the prognosis of stage II colorectal cancer patients and identifying candidates for chemotherapy.DNA倍体联合肿瘤基质作为预测II期结直肠癌患者预后及识别化疗候选者的生物标志物。
World J Surg Oncol. 2025 Feb 13;23(1):49. doi: 10.1186/s12957-025-03693-6.
2
Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients.探索DNA倍体、基质-肿瘤比例和核型分析在II期结肠癌患者中的预后价值。
Discov Oncol. 2024 Jun 14;15(1):227. doi: 10.1007/s12672-024-01087-w.
3
Calibration-Aimed Comparison of Image-Cytometry- and Flow-Cytometry-Based Approaches of Ploidy Analysis.
基于图像细胞仪和流式细胞仪的倍性分析方法的校准比较。
Sensors (Basel). 2022 Sep 14;22(18):6952. doi: 10.3390/s22186952.
4
Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma.自动化评估DNA倍性、染色质组织和基质分数以预测II期结直肠癌患者的预后和辅助治疗反应。
Am J Cancer Res. 2021 Dec 15;11(12):6119-6132. eCollection 2021.
5
Stromal composition predicts recurrence of early rectal cancer after local excision.基质成分可预测局部切除后早期直肠癌的复发。
Histopathology. 2021 Dec;79(6):947-956. doi: 10.1111/his.14438. Epub 2021 Sep 3.
6
A DNA quantitative analysis of lung cancer cells with different pathological types from bronchial brush specimens and its clinical significance.支气管刷检标本中不同病理类型肺癌细胞的DNA定量分析及其临床意义
Int J Clin Exp Pathol. 2020 Aug 1;13(8):2106-2114. eCollection 2020.
7
The Correlation between EGFR Mutation Status and DNA Content of Lung Adenocarcinoma Cells in Pleural Effusion.胸腔积液中肺腺癌细胞EGFR突变状态与DNA含量的相关性
J Cancer. 2020 Feb 6;11(8):2265-2272. doi: 10.7150/jca.38615. eCollection 2020.
8
A prospective comparison of conventional cytology and digital image analysis for the identification of pancreatic malignancy in patients undergoing EUS-FNA.在接受超声内镜引导下细针穿刺活检(EUS-FNA)的患者中,对传统细胞学检查和数字图像分析用于识别胰腺恶性肿瘤的前瞻性比较。
Endosc Ultrasound. 2019 Jul-Aug;8(4):269-276. doi: 10.4103/eus.eus_9_19.
9
Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading.通过 DNA 倍体分析和异型增生分级预测临床高危病变的恶性进展。
Sci Rep. 2018 Oct 26;8(1):15874. doi: 10.1038/s41598-018-34165-5.
10
Chromatin organisation and cancer prognosis: a pan-cancer study.染色质组织与癌症预后:泛癌症研究。
Lancet Oncol. 2018 Mar;19(3):356-369. doi: 10.1016/S1470-2045(17)30899-9. Epub 2018 Feb 3.